- March 25, 2015
Lab Fee Waivers Could Be Kickbacks, OIG Warns
A laboratory’s proposal to waive fees for certain patients referred by physician practices could violate the Anti-Kickback Statute and result in serious discipline, according to an opinion released Wednesday by the Office of Inspector General at the U.S. Department of Health and Human Services.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, March 26, 2015
Lab Fee Waivers Could Be Kickbacks, OIG Warns
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment